119 related articles for article (PubMed ID: 8864383)
1. Chloroquine: consideration of maximum daily dose (3.5 mg/kg ideal body weight) prevents retinopathy.
Ochsendorf FR; Runne U
Dermatology; 1996; 192(4):382-3. PubMed ID: 8864383
[No Abstract] [Full Text] [Related]
2. Chloroquine retinopathy.
Lakanapichonchat T
J Med Assoc Thai; 1977 Nov; 60(11):576-81. PubMed ID: 591805
[No Abstract] [Full Text] [Related]
3. Antimalarials in the management of discoid and systemic lupus erythematosus.
Dubois EL
Semin Arthritis Rheum; 1978 Aug; 8(1):33-51. PubMed ID: 358397
[No Abstract] [Full Text] [Related]
4. [Multimodal imaging of hydroxychloroquine and chloroquine retinopathy].
Sellam A; Massamba N; Le Hoang P; Bodaghi B
J Fr Ophtalmol; 2016 Jan; 39(1):111-3. PubMed ID: 26631575
[No Abstract] [Full Text] [Related]
5. [Chloroquine retinopathy: preventable by monitoring the maximum daily dose].
Ochsendorf FR; Runne U
Hautarzt; 1988 Jun; 39(6):341-2. PubMed ID: 3403271
[TBL] [Abstract][Full Text] [Related]
6. Discoid lupus erythematosus.
Brown RK
Arch Dermatol; 1972 May; 105(5):768-70. PubMed ID: 4537259
[No Abstract] [Full Text] [Related]
7. Chronic discoid lupus erythematosus with chloroquine retinopathy.
McCarthy JT
Arch Dermatol; 1971 Jul; 104(1):109-10. PubMed ID: 4256261
[No Abstract] [Full Text] [Related]
8. Factors associated with chloroquine-induced retinopathy in rheumatic diseases.
Araiza-Casillas R; Cárdenas F; Morales Y; Cardiel MH
Lupus; 2004; 13(2):119-24. PubMed ID: 14995005
[TBL] [Abstract][Full Text] [Related]
9. Chloroquine-induced myopathy.
Posada C; García-Cruz A; García-Doval I; Millán BS; Teijeira S
Lupus; 2011 Jun; 20(7):773-4. PubMed ID: 21300683
[No Abstract] [Full Text] [Related]
10. [Chloroquine retinopathy: avoidable by individualized daily dosing].
Ochsendorf FR; Runne U; Goerz G; Zrenner E
Dtsch Med Wochenschr; 1993 Dec; 118(51-52):1895-8. PubMed ID: 8287780
[No Abstract] [Full Text] [Related]
11. Dose relationships in patients with early chloroquine retinopathy.
Easterbrook M
J Rheumatol; 1987 Jun; 14(3):472-5. PubMed ID: 3625628
[TBL] [Abstract][Full Text] [Related]
12. Screening for chloroquine retinopathy.
Earnshaw ER; Miles DW; Stewart TW
Br J Dermatol; 1966 Dec; 78(12):669-74. PubMed ID: 5955593
[No Abstract] [Full Text] [Related]
13. Antimalarial therapy in SLE.
Lanham JG; Hughes GR
Clin Rheum Dis; 1982 Apr; 8(1):279-98. PubMed ID: 6749400
[No Abstract] [Full Text] [Related]
14. Ocular changes after treatment of chronic discoid lupus erythematosus with chloroquine.
Handa F; Chopra A; Aggarwal RR; Bansal DC
Indian J Dermatol; 1983 Oct; 28(4):145-8. PubMed ID: 6671702
[No Abstract] [Full Text] [Related]
15. [The visual system in 30 subjects with discoid lupus erythematosus treated with hydroxychloroquine].
Rossi A; Rinaldi M; Vozza A; Romano A; Turco P
G Ital Dermatol Venereol; 1988 Apr; 123(4):189-92. PubMed ID: 3182010
[No Abstract] [Full Text] [Related]
16. [On chloroquine hypersensitivity in lupus erythematosus].
Sönnichsen N; Nebe H
Dermatol Wochenschr; 1965 Aug; 151(35):1031-4. PubMed ID: 5843495
[No Abstract] [Full Text] [Related]
17. [Treatment of patients with discoid lupus erythematosus by injections of 10 per cent Quingamine].
Zheltakov MM; Sharapova GIa; Khamaganova AV; Berezhnoĭ IuZ
Vestn Dermatol Venerol; 1969 Dec; 45(12):8-11. PubMed ID: 5375472
[No Abstract] [Full Text] [Related]
18. [Delagyl-dimethylsulfoxide liniments in combined therapy of discoid lupus erythematosus].
Sergeev VP
Sov Med; 1971 Nov; 34(11):152-3. PubMed ID: 5160631
[No Abstract] [Full Text] [Related]
19. The association of the two antimalarials chloroquine and quinacrine for treatment-resistant chronic and subacute cutaneous lupus erythematosus.
Feldmann R; Salomon D; Saurat JH
Dermatology; 1994; 189(4):425-7. PubMed ID: 7873836
[TBL] [Abstract][Full Text] [Related]
20. Chloroquine retinopathy.
Felton JM
Trop Doct; 1997 Jan; 27(1):2-4. PubMed ID: 9030009
[No Abstract] [Full Text] [Related]
[Next] [New Search]
